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Abstract: 
Inadequate control of high systolic blood pressure in older adults has been largely attributable to 
poor control of overall hypertension (HTN). The Seventh Report of the Joint National 
Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) 
guidelines emphasize the importance of controlling isolated systolic HTN in older adults. The 
study examined demographics, self-reported health information, and clinical measures as 
predictors of uncontrolled HTN among individuals taking antihypertensive medications. The 
Community Initiative to Eliminate Stroke, a stroke risk factor screening and prevention project, 
collected data in two North Carolina counties. Statistical modeling of predictors included odds 
ratios (ORs) and logistic regression analyses. Of the 2663 participants, 43.5% and 22.8% had 
uncontrolled systolic and diastolic HTN, respectively. African Americans were more likely to 
have uncontrolled systolic (60%) or diastolic HTN (70.9%) compared with whites (40% and 
29.1%, respectively). Participants 55 years and older were more likely to have uncontrolled 
systolic HTN compared with younger individuals. Regression analyses showed that race (OR, 
1.239; P=.00), age (OR, 1.683; P=.00), and nonadherence with medications (OR, 2.593; P=.00) 
were significant predictors of uncontrolled systolic HTN. Future interventions should focus on 
improving management of isolated systolic HTN in older adults and African Americans to 
increase overall control of HTN. 
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Article: 
Hypertension (HTN) is a major risk factor for cardiovascular diseases (CVD) and 
stroke.[1] HTN was either the primary or contributing cause of death for more than 300,000 
Americans in 2006.[2, 3] The National High Blood Pressure Education Program (NHBPEP) and 
the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and 
Treatment of High Blood Pressure (JNC 7) have stipulated guidelines for treatment and control 
of HTN. These guidelines serve as a platform for healthcare providers, public health researchers, 
and practitioners to focus on key elements of lifestyle modification and pharmacologic aspects of 
HTN management.[4,5] Due to ongoing efforts of NHBPEP, the number of individuals in the 
United States who are taking medication and thus controlling their BP levels has increased 
dramatically during the past 2 decades. But, according to the National Health and Nutrition 
Examination Survey (NHANES) 2001–2010 report, despite an increase in overall BP control 
rates by 47.2% (NHANES 2009–2010) compared with 28.7% (NHANES 2001–2002), 
approximately 40% of treated hypertensive patients did not have controlled BP levels by the 
2009 to 2010 time period.[6] 
In spite of continued efforts to treat and control HTN at a national level, success has been 
limited.[7] Furthermore, there are concerns that the trends described in the NHANES report may 
not be relevant to vulnerable populations. Their findings also showed persistent higher treated 
but uncontrolled HTN rates among older Americans.[6] An earlier NHANES study found that, 
although the elderly population (65 years or older) represented roughly one fifth of the total 
population, they represented almost a half of those unaware of their condition, a third of those 
who were aware of their condition but not being treated, and over half of those who had treated 
but uncontrolled HTN. A 2011 report from Aronow and colleagues[8] found that many factors, 
including use of multiple pharmacies, medication side effects, medication costs, and 
comorbidities, contribute to uncontrolled HTN in the elderly. Similar findings were reported in 
studies examining data collected in the 1990s from the Framingham Heart Study (FHS).[9] 
In addition to age, race is another demographic factor that researchers have found to be 
associated with uncontrolled HTN rates. A study looking at data from the Multi-Ethnic Study of 
Atherosclerosis (MESA) found that across whites, Hispanics, Chinese, and African Americans, 
only African Americans shared a significant association with treated but uncontrolled HTN. 
They also recommended that future research specifically focus on strategies to prevent 
hypertension in these high-risk groups.[10] A Central North Carolina (NC) study examining 
racial differences in an elderly hypertensive population found that after adjusting for 
confounding variables, black race was an independent risk factor for HTN in the elderly. A large 
number of studies have also shown sex disparities associated with uncontrolled HTN. For 
example, a study examining data collected by the National Ambulatory Medical Care Survey and 
the National Hospital Ambulatory Medical Care Survey found that women in their sample were 
more likely to have uncontrolled HTN compared with men.[11] Research conducted in Ingham 
County, Michigan, found that female sex was a significant predictor of BP control.[12] Another 
study exploring HTN in the Iranian population found supporting evidence, emphasizing the need 
for advisement on monitoring and controlling HTN in women.[13] 
Nonadherence to BP-lowering medications and recommendations is also cited as one of the 
leading contributing factors to uncontrolled HTN, especially among minority and elderly 
populations. About half of all patients with HTN fail to consistently attend appointments and 
take prescribed medications. According to The Cohort Study of Medication Adherence in Older 
Adults (CoSMO), a prospective study among older adults with essential HTN, the authors found 
that black participants not only had a significantly higher prevalence of uncontrolled HTN, but 
also had a lower level of adherence to BP-lowering medications compared with whites. This 
study reported a strong association between self-reported nonadherence and uncontrolled BP 
levels determined by clinical readings.[14] Vawter and colleagues conducted a study to assess 
barriers to antihypertensive medication adherence among adults in the United States. The authors 
found that almost one third of the participants reported several barriers to antihypertensive 
therapy. “Not remembering” was the most common reason reported (32.4%), followed by high 
cost (22.6%), having no insurance (22.4%), side effects (12.5%), and other reasons.[15] 
Hyman and Pavlik examined NHANES III data and found that SBP is most strongly related to 
age, and accounts for the majority of uncontrolled HTN cases in individuals 60 years and 
older.[16, 17] Systolic HTN prevalence rates increase with age, and SBP level is the main risk 
factor for CVD after the age of 50 years.[16,18] The JNC 7 report suggests that there is a greater 
need to focus on isolated SBP as a major risk factor for CVD and strokes. Studies have shown 
that SBP levels continue to rise throughout life, whereas DBP levels start to taper off after 
50 years of age.[19, 20] Franklin and colleagues explored the hemodynamic patterns of age-
related changes in BP and found that age-related changes leading to increasing SBP levels and 
decreasing DBP levels after 50 years of age are mainly attributed to large artery stiffness. They 
also suggest that the dominant hemodynamic factor in normotensive and hypertensive 
individuals is large artery stiffness compared with vascular resistance. If HTN is left untreated or 
uncontrolled, large artery stiffness would worsen, thereby perpetuating a vicious cycle of 
elevated BP levels and arterial stiffness.[20] 
In many of these vulnerable populations, the uncontrolled BP cycle is easily maintained by a host 
of other barriers and factors that affect an individual's ability to meet BP goals.[21] Some of 
these include lack of support, lack of clarity and knowledge about their condition,[22, 
23]physician inertia,[24-26] resistant HTN,[27, 28] comorbidities (diabetes, renal 
disease),[29] and adherence to prescribed medication.[30-35] For instance, in 2011, Persell 
examined NHANES data from 2003–2008 and found that 8.9% among all hypertensive adults 
and 12.8% among drug-treated hypertensive adults had resistant HTN in the United States. 
Resistant HTN was defined as having uncontrolled HTN (≥140/90 mm Hg) in spite of taking 
antihypertensive drugs from ≥3 drug classes or having controlled HTN after taking 
antihypertensive drugs from ≥4 drug classes. The author also noted that older age, black race, 
high BMI, and renal dysfunction was significantly associated with resistant HTN.[27] Pimenta 
and Calhoun (2012) reported an increasing trend in the prevalence of resistant HTN from 5.5% 
in 1988–1994 to 11.8% in 2005–2008. This trend has also increased CVD risk substantially 
among individuals with uncontrolled HTN compared with those who have controlled BP levels 
after taking ≥3 antihypertensive medications.[28] 
Researchers have suggested that future research should focus on groups with the highest risk, 
including but not limited to black women and the elderly, and consider strategies to further 
understand the trends and patterns of uncontrolled HTN in these communities.[36] The 
relationship between demographics and other barriers specific to these populations should be 
further examined in developing a strategy to improve HTN control in this population.[14, 37] 
In order to better develop and implement interventions that are population-specific, culturally 
competent, and community-based, it is important to understand and assess factors associated 
with uncontrolled HTN. This study aims to assess demographic, self-reported, and clinical 
predictors of uncontrolled HTN among individuals taking BP-lowering medications and add to 
the existing literature to better inform strategies and interventions aimed at improving HTN 
control in elderly and underrepresented populations. 
Methods 
CITIES Project 
The CITIES Project of NC was supported for 3 years by the US DHHS, Office of Minority 
Health (OMH), and awarded to the Forsyth Medical Center (FMC) Foundation in formal 
partnership with the Cone Health, the University of North Carolina at Greensboro (UNCG), and 
the North Carolina Agriculture & Technical State University (NC A&T). This initiative was 
implemented in two NC counties, Guilford and Forsyth, and targeted minority populations, low-
income individuals, those who spoke English as a second language, and persons who lived in 
rural areas. The main components of the CITIES project were to: (1) screen individuals for 
stroke risk factors; (2) make recommendations and referrals as appropriate for identified risk 
factors; and (3) provide health education and health promotion activities regarding stroke risk 
factors.[38] 
Settings and Procedures 
Each medical center used a mobile unit and registered nurses (RN) to screen individuals with 
preset appointments at designated sites in both counties, such as churches, factories, and health 
fairs and at sites with unscheduled appointments such as shopping mall parking lots, within the 
two respective counties. Participation was voluntary and each participant was included if they 
were 18 years or older and signed the consent form. The RNs used a standard questionnaire that 
gathered data on self-reported questions, stroke risk profile, and clinical and biomedical 
measurements. A total of 19,621 individuals were screened for stroke risk factors in the CITIES 
project. Of those, 2663 individuals who were taking BP-lowering medications were chosen for 
this study. The participants were asked to self-report their HTN medication status by answering 
the following question: “Do/Did you take any medications to control your blood pressure?” 
Inclusion in the sample was based on a “yes” response to the question about BP-lowering 
medications. 
The RNs measured the BP of each participant using an electronic machine, DYNAMAP, which 
was wet-tested and calibrated every week. A minimum of 2 measurements were taken in the 
seated position with one of the arms outstretched and the lowest BP reading was recorded. If the 
first reading was high, ie, high systolic and/or diastolic BP, then BP was measured again after 
2 minutes in the same arm. If the readings on the machine were found to be high on both 
occasions, then the RNs would manually measure the BP twice in the other arm, using a 
calibrated sphygmomanometer, and then record the lowest readings. All participants who had a 
BP measurement of 160 mm Hg for systolic and/or 100 mm Hg for diastolic or higher were 
referred to an emergency department promptly to get their BP checked again. All cut-points for 
uncontrolled HTN, SBP, and DBP levels were based on the JNC 7 definition and classification 
of HTN.[5] 
Other self-reported information included perceived weight status, smoking, exercise status, 
presence or absence of diabetes mellitus, nonadherence with BP-lowering medications and use of 
lipid-lowering medications.[38] All self-reported information was collected prior to collection of 
blood samples and recording of clinical and biomedical measurements. Clinical and biomedical 
measurements included blood low-density lipoprotein (LDL), high-density lipoprotein (HDL), 
total cholesterol, triglycerides, and glucose levels. BMI was calculated based on self-reported 
height and measured weight. The project was approved by the respective institutional review 
boards for each institution. The RNs also collected demographic information from all 
participants. Age was dichotomized into two groups, 55 years and younger and older than 55 
years. 
Statistical Analyses 
MS Access was used to input data, which was analyzed using IBM SPSS Statistics 20©.[39, 
40] The final sample excluded individuals who were not taking BP-lowering medications in 
order to avoid confounding results. The participants' demographic characteristics, self-reported 
information, and clinical measurements were described using frequencies and percentages. 
Bivariate associations were calculated using cross-tabulations to compare self-reported 
information (yes and no) from the questionnaire with uncontrolled levels of SBP and DBP (yes 
and no) based on clinical measurements. 
Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using standard procedures 
to assess determinants of uncontrolled SBP and DBP. Uncontrolled SBP and DBP, the outcome 
variables, were modeled as a function of independent variables including demographic 
characteristics, self-reported information, and clinical measurements reported. Binary logistic 
regression and forward likelihood ratio method were used to evaluate statistically significant 
predictors of BP control. Separate regression analyses were conducted on a subsample of 
individuals who self-reported to be compliant with BP-lowering medications. The Hosmer and 
Lemeshow Goodness-of-Fit test was conducted to assess the fit of the final model and its 
estimates. The statistical significance for all analyses was based on the conventional α level of 
significance of 0.05. 
Results 
A total of 2663 participants who reported that they did or were taking BP-lowering medications 
were included in the final analysis. A description of demographic characteristics is provided in 
Table 1. More than two thirds of the participants were women. A majority of the participants 
were African American (52.2%) and 42% were white. Almost 50% of the participants had a high 
school level education or more. 
Table 1. Demographic Characteristics of Respondentsa in the CITIES Project, NC 2004–2007 
Personal Characteristics Total 
(N=2663) % 
Sex 
Female 1840 69.3 
Male 816 30.7 
Race 
Caucasian 1118 42.0 
African American 1391 52.2 
Hispanic 14 0.5 
Asian/Pacific Islander 44 1.7 
Other 52 2.0 
Age, y 
18–55 1238 46.7 
>55 1412 53.3 
Income, $ 
<35,000 1782 70.7 
≥35,000 738 29.3 
Education 
Less than high school 193 7.4 
High school or GED 1008 38.8 
More than high school 1396 53.8 
Ethnicity 
Hispanic/Latino 44 1.7 
Non-Hispanic/Latino 2575 98.3 
a Totals do not sum to the sample size due to missing data. 
Almost one third of the participants had LDL and HDL levels in the high-risk categories 
(Table 2). Approximately 40% of the participants had moderate to high total blood cholesterol 
and triglyceride levels. Less than 10% of the sample size had nonfasting blood glucose levels 
>150 mg/dL. Two thirds of the participants were either overweight or obese based on their BMI 
levels. The mean SBP and DBP levels were 138.39 mm Hg (standard deviation=19.58) and 
81.67 mm Hg (standard deviation=10.65), respectively. The prevalence of uncontrolled systolic 
HTN and diastolic HTN in our population sample was 43.5 and 22.8, respectively. 
Table 2. Clinical Characteristics of Respondentsa in the CITIES Project, NC 2004–2007 
Clinical Characteristics Total 
(N=2663) % 
LDL 
Optimum (≤99 mg/dL) 641 30.9 
Near optimum/above optimum (100–129 mg/dL) 833 40.1 
Borderline high risk (130–159 mg/dL) 434 20.9 
High risk (160–189 mg/dL) 129 6.3 
Very high risk (≥190 mg/dL) 38 1.8 
HDL 
Preventive (≥60 mg/dL) 602 23.0 
Normal (40–59 mg/dL) 1244 47.6 
High risk (<40 mg/dL) 770 29.4 
Total cholesterol 
Normal (≤199 mg/dL) 1649 62.7 
Moderate risk (200–239 mg/dL) 741 28.2 
High risk (≥240 mg/dL) 240 9.1 
Triglyceride 
Optimum (≤149 mg/dL) 1385 52.7 
Borderline high risk (150–199 mg/dL) 479 18.2 
High risk (≥200 mg/dL) 762 29.0 
Blood glucose 
Normal (50–149) 2359 89.9 
Moderate risk (150–199 mg/dL) 174 6.6 
High risk (≥200 mg/dL) 92 3.5 
BMI 
Underweight (≤18.5) 24 0.9 
Normal (18.5–24.9999) 436 16.5 
Overweight (25–29.9999) 885 33.5 
Obese (≥30) 1295 49.1 
Systolic BP 
Controlled (normal) (≤140 mm Hg) 1485 56.5 
Uncontrolled (≥140 mm Hg) 1141 43.5 
Diastolic BP 
Controlled (normal) (≤90 mm Hg) 2022 77.2 
Uncontrolled (≥90 mm Hg) 598 22.8 
Combined systolic and diastolic BP 
Controlled (normal) 2121 81.5 
Uncontrolled 480 18.5 
Abbreviations: BMI, body mass index; BP, blood pressure; HDL, high-density lipoprotein; LDL, 
low-density lipoprotein. 
a Totals do not sum to the sample size due to missing data. 
 
A description of self-reported information is presented in Table 3. Less than 15% of the 
participants reported a personal history while one third reported a family history of CVD. 
Slightly more than half (52.6%) of the participants reported a lack of exercise in their daily lives, 
while more than half of the participants reported that they were overweight. Approximately one 
fifth of the participants reported having diabetes. Less than 10% of the population sample 
reported nonadherence with their BP-lowering medications, citing forgetfulness, side effects, and 
high cost as potential reasons for nonadherence. 
Table 3. Self-Reported Characteristics of Respondentsa in the CITIES Project, NC 2004–2007 
Self-Reported Characteristics Total 
(N=2663) % 
History of CVD 
No 2281 85.7 
Yes 382 14.3 
History of atrial fibrillation 
No 2548 95.7 
Yes 115 4.3 
Family history of CVD 
No 1774 66.6 
Yes 889 33.4 
Smoking 
No 2256 84.7 
Yes 407 15.3 
Overweight status 
No 941 35.3 
Yes 1722 64.7 
Lack of exercise status 
No 1263 47.4 
Yes 1400 52.6 
High blood cholesterol status 
No 1497 56.2 
Yes 1166 43.8 
Diabetes status 
No 2102 78.9 
Yes 561 21.1 
Stress status 
No 2044 76.8 
Yes 619 23.2 
Noncompliance with BP-lowering medications 
No 2453 92.1 
Yes 210 7.9 
Due to high costs 29 14.4 
Due to side effects 45 22.4 
Due to forgetfulness 56 27.9 
Due to other reasons 71 35.3 
Abbreviations: BP, blood pressure; CVD, cardiovascular disease. 
a Totals do not sum to sample size due to missing data. 
 
A significant correlation was observed between age of participants and SBP (.130, P<.05) and 
DBP (−.205, P<.05). A multivariate logistic regression using a stepwise forward likelihood ratio 
indicated that nonadherence to BP-lowering medications (OR, 2.450; P=.00), age (OR, 
1.666; P=.00), race (OR, 1.558; P=.00), blood triglyceride levels (OR, 1.490; P=.00), and blood 
glucose levels (OR, 2.107; P=.01), were significant predictors of uncontrolled SBP levels 
(Table 4). Black patients, individuals older than 55 years self-reported to be nonadherent with 
BP-lowering medications, with high risk levels of blood glucose and a moderate risk for blood 
triglyceride levels were more likely to have uncontrolled SBP levels compared with the reference 
groups. A multivariate logistic regression using a stepwise forward likelihood ratio also indicated 
that age (OR, 0.461; P=.00), race (OR, 2.173; P=.00), sex (OR, 1.953, P=.00), nonadherence 
with BP-lowering medications (OR, 2.342; P=.00), personal history of atrial fibrillation (OR, 
0.477; P=.03), and smoking (OR, 1.376; P=.03) were significant predictors of uncontrolled DBP 
levels. The final model showed that men, blacks, individuals 55 years or younger, smokers, and 
those with no personal history of atrial fibrillation were more likely to have uncontrolled DBP 
levels compared with the reference groups. 
Table 4. Logistic Regression: Predictors of Uncontrolled SBP and DBP by Demographic, Self-
Reported, and Clinical Characteristics in the CITIES Project, NC 2004–2007 
Participant Characteristics β SBP Odds Ratio (95% CI) P Value 
Adherence to BP medications 
Yes (reference) – – – 
No 0.896 2.450 (1.738–3454)a .00 
Age, y 
18–55 (reference) – – – 
>55 0.510 1.666 (1.376–2.017)a .00 
Race 
Caucasian (reference) – – – 
African Americans 0.443 1.558 (1.272–1.908)a .00 
Hispanics/Latinos 0.671 1.957 (0.508–7.541) .32 
Asians/Pacific Islander 0.487 1.627 (0.779–3.396) .19 
Others 0.452 1.572 (0.796–3.105) .19 
Triglycerides 
Normal (reference) – – – 
Moderate risk 0.399 1.490 (1.164–1.907)a .00 
High risk 0.217 1.242 (0.982–1.571) .07 
Blood glucose 
Normal (reference) – – – 
Moderate risk −0.069 0.933 (0.610–1.427) .74 
High risk 0.745 2.107 (1.171–3.791)a .01 
Participant Characteristics β DBP Odds Ratio (95% CI) P Value 
Age, y 
18–55 (reference) – – – 
>55 −0.775 0.461 (0.367–0.579)a .00 
Race 
Caucasian (reference) – – – 
African Americans 0.776 2.173 (1.708–2.765)a .00 
Hispanics/Latinos 0.919 2.507 (0.588–10.682) .21 
Asians/Pacific Islander 1.050 2.857 (1.309–6.233)a .00 
Others 0.290 1.337 (0.580–3.082) .49 
Gender 
Female (reference) –   – 
Male 0.669 1.953 (1.543–2.472)a .00 
Adherence to BP medications 
Yes (reference) –   – 
No 0.808 2.242 (1.580–3.183)a .00 
History of atrial fibrillation 
No (Reference) –     
Yes −0.741 0.477 (0.242–0.938)a .03 
Smoking status 
Nonsmoker (Reference) –     
Smoker 0.320 1.376 (1.029–1.842)a .03 
Abbreviations: BP, blood pressure; CI, confidence interval; DBP, diastolic blood pressure; SBP, 
systolic blood pressure.a Significant at P<.05. 
In order to further evaluate, compare, and ascertain differences in the predictors of uncontrolled 
HTN for all individuals and a subsample of individuals who self-reported to be compliant with 
their medication recommendations, multivariate logistic regression analyses using a stepwise 
forward likelihood ratio using this subsample were performed. Age (OR, 1.682; P=.00), race 
(OR, 1.561; P=.00), and blood triglyceride levels (OR, 1.519; P=.00) were significant predictors 
of uncontrolled SBP levels (Table 5). African Americans, individuals older than 55 years, and 
those with high risk levels of blood triglycerides were more likely to have uncontrolled SBP 
levels compared with the reference groups. With the exception of high-risk blood glucose levels, 
these 3 predictors were also significantly associated with uncontrolled SBP for all individuals 
taking antihypertensive individuals. Age (OR, .508; P=.00), race (OR, 2.172; P=.00), sex (OR, 
1.864;P=.00), and personal history of atrial fibrillation (OR, 0.374; P=.01) were significant 
predictors of uncontrolled DBP levels. Men, African Americans, individuals younger than 
55 years, with no personal history of atrial fibrillation were more likely to have uncontrolled 
DBP levels compared with the reference groups. With the exception of smoking status, these 3 
predictors were also significantly associated with uncontrolled SBP for all individuals taking 
antihypertensive individuals. 
Table 5. Logistic Regression: Predictors of Uncontrolled SBP and DBP by Demographic, Self-
Reported, and Clinical Characteristics Among Compliant Participants in the CITIES Project, NC 
2004–2007 
Participant Characteristics β SBP Odds Ratio (95% CI) P Value 
Age, y 
18–55 (reference) – – – 
>55 0.520 1.682 (1.380–2.050)a .00 
Race 
Caucasian (reference) – – – 
African Americans 0.446 1.561 (1.267–1.924)a .00 
Hispanics/Latinos 1.020 2.773 (0.643–1.968) .17 
Asians/Pacific Islander 0.534 1.706 (0.822–3.542) .15 
Others 0.270 1.309 (0.636–2.697) .46 
Blood triglyceride levels 
Normal (reference) – – – 
Moderate risk 0.418 1.519 (1.179–1.958)a .00 
High risk 0.186 1.205 (0.943–1.539) .13 
Participant Characteristics β DBP Odds Ratio (95% CI) P Value 
Age, y 
18–55 (reference) – – – 
>55 −0.677 0.508 (0.401–0.644)a .00 
Race 
Caucasian (reference) – – – 
African Americans 0.775 2.172 (1.686–2.797)a .00 
Hispanics/Latinos 1.172 3.228 (0.735–14.165) .12 
Asians/Pacific Islander 1.056 2.876 (1.327–6.231)a .00 
Others −0.063 0.939 (0.350–2.516) .90 
Sex 
Female (reference) – – – 
Male 0.623 1.864 (1.456–2.385)a .00 
History of atrial fibrillation 
No (reference) – – – 
Yes −0.983 0.374 (0.168–0.835)a .01 
Abbreviations: CI, confidence interval; DBP, diastolic blood pressure; SBP, systolic blood 
pressure. aSignificant at P<.05. 
Discussion 
The mean SBP and DBP levels of our sample fell into the classification for pre-HTN for high BP 
(JNC 7). The control rates for HTN in our cross-sectional population were slightly higher than 
the national rates and for those reported in other studies.[3,6,41,42] Among those who had 
comorbidities associated with HTN, approximately 25% of the population sample self-reported 
as having diabetes mellitus. In addition, two thirds of our population was either overweight or 
obese based on their BMI levels. Approximately 40% of the participants also had high blood 
cholesterol and triglyceride levels. The presence of comorbidities such as diabetes mellitus and 
high-risk BMI levels further compounds achievement of BP control.[41] 
Despite continued efforts to reduce disparities in management and control of HTN, our results 
indicate that African Americans are at greater risk for both uncontrolled systolic and diastolic 
HTN. Fongwa and colleagues[43] conducted a qualitative study to evaluate and assess barriers to 
and facilitators of medication adherence among hypertensive African American women 35 years 
and older. They conducted 5 focus groups and found that barriers to effective control of high BP 
were mainly associated with side effects, cost of medications, personal stress, stress from the 
social system, socioeconomic status, and lack of physical activity among other barriers. The 
authors also found that facilitators to effective control included, but were not limited to, positive 
and proactive behavioral and lifestyle changes. 
A similar study conducted by Ogedegbe and colleagues[44] found that among hypertensive 
African American patients in two primary care centers, patient-specific barriers were most 
commonly reported. These barriers included forgetfulness, beliefs that medications are 
undesirable and cause impotency, and attitudes such as not taking responsibility for one's health. 
Other barriers included medication-specific issues, such as side effects and cost; disease-specific 
issues, such as absence of symptoms vs having symptoms; and logistic-specific issues, such as 
access to health care and medications. The findings of these studies are consistent with the 
results of our analyses and other studies conducted among African American populations.[45-48] 
Hyman and Pavlik[16] found that individuals who were at least 65 years were associated with 
the highest relative risk and attributable risk of uncontrolled HTN. Our findings suggest that 
individuals who are older than 55 years were at the greatest risk for failure to control their SBP 
levels whereas younger individuals were more likely to experience uncontrolled DBP levels. 
Similar findings have been reported in other studies that investigated the role of SBP and DBP 
levels in coronary heart disease risk change with aging.[20,49] Other studies have also shown 
that lack of control of SBP as a result of inadequate management are largely responsible for poor 
overall control of HBP levels in the US population.[2,16,19,50] Growing evidence supports the 
notion that physicians should focus on controlling elevated SBP particularly in older 
individuals.[31,51] Studies that have surveyed physicians have shown that three fourths did not 
initiate appropriate treatment in older individuals with SBP of ≥140 mm Hg. Moreover, most 
providers did not pursue NHBPEP-stipulated goals of controlling SBP to levels <140 mm 
Hg.[50,26] JNC 7 reports that most physicians are trained to focus on DBP levels and treat it 
accordingly, as opposed to SBP levels, which have a more dire effect on individuals affected by 
HTN after the age of 50 years. Our findings support the recommendation purported by NHBPEP 
to focus on controlling SBP as a means to effectively manage HTN particularly in older adults. 
Based on our findings, it is also recommended for practitioners to design interventions and focus 
on targeting men, African Americans, and younger individuals to control their DBP levels. 
Study Strengths and Limitations 
The strengths of this study include a large cross-sectional sample size and the availability of 
clinical and biomedical markers of CVD and stroke risk factors. This study focuses on regional 
assessment of uncontrolled HTN particularly in the stroke belt state of NC, which has one of the 
highest stroke mortality rates in the United States. One limitation of this study was that only two 
readings of clinical measures of BP were collected. This may have led to overestimation of HTN. 
Individual BP levels vary throughout the day and from day to day; therefore, a more stringent 
criterion is recommended to diagnose HTN.[52-56] Another limitation of this study was that the 
researchers did not collect information on the type of BP-lowering medications taken by the 
population sample. This would have allowed the authors to assess the effects of medications in 
controlling SBP and/or DBP levels and provide pharmacologic linkage to management of HTN. 
Less than 10% (n=210) of participants indicated nonadherence to BP-lowering medications. 
Nonadherence to medications can be defined as not following clinically prescribed 
recommendations of regularly taking BP-lowering medications. We did not collect information if 
the participants were taking pills on alternate days or taking half the recommended dosage or 
were taking medications when he/she perceived symptoms related to high BP. It is quite possible 
that the number in our sample could have been higher if more accurate information was gathered 
concerning nonadherence. 
Conclusions 
During the past several decades, numerous studies have comprehensively evaluated the 
information regarding predictors of uncontrolled BP levels, such as demographic characteristics, 
self-reported comorbidities, and clinical correlates of hypertension that are consistent with the 
findings of this study. Age, race, and medication nonadherence are significant predictors of both 
isolated uncontrolled SBP and DBP levels. In addition, we found similar results for individuals 
who were adherent with BP-lowering medications. This article intends to further support calls for 
strategies and interventions that focus on factors unique to the elderly and underrepresented 
populations to better control BP levels and eliminate disparities. Although the efforts of the 
NHBPEP have shown improvements in awareness, treatment, and control of BP, one third of the 
US population still has uncontrolled HTN. Black patients are more prone to experience 
uncontrolled HTN as compared with other racial/ethnic groups. This finding maintains 
recommendations that future research should tend to the minorities and consider the barriers 
specific to this group. Several studies have also shown that uncontrolled BP levels are mainly 
attributable to systolic pressure. JNC 7 has emphasized the need for practitioners and public 
health professionals to focus on controlling SBP levels among hypertensive populations. Further 
research and clinical trials may be warranted to support this plan of action. A total of 43% of our 
sample had uncontrolled systolic HTN. Future drug trials could elucidate the differential effects 
of BP-lowering medications on controlling isolated SBP or DBP levels. There is also a growing 
need for healthcare providers to better manage and target systolic HTN to achieve better overall 
control of HTN particularly in older populations. Finally, public health research and 
interventions for HTN and other correlated CVD risk factors should be designed to reduce sex 
and racial disparities. 
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